Home > Publications database > Considerations for delivery of live-remote exercise for people with cancer in research and practice. > print |
001 | 303953 | ||
005 | 20250821114622.0 | ||
024 | 7 | _ | |a 10.1093/jncimonographs/lgaf029 |2 doi |
024 | 7 | _ | |a pmid:40828162 |2 pmid |
024 | 7 | _ | |a 1052-6773 |2 ISSN |
024 | 7 | _ | |a 1745-6614 |2 ISSN |
037 | _ | _ | |a DKFZ-2025-01728 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Zopf, Eva M |0 0000-0001-6250-0041 |b 0 |
245 | _ | _ | |a Considerations for delivery of live-remote exercise for people with cancer in research and practice. |
260 | _ | _ | |a Oxford |c 2025 |b Oxford Univ. Press |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1755758258_3180 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Exercise is safe and beneficial for people diagnosed with cancer. The use of live-remote exercise approaches, where exercise trainers deliver exercise programs via a videoconferencing platform, has increased rapidly, greatly expanding the reach of exercise programs. This method retains key elements of supervised exercise, which provide greater benefits than unsupervised programs. However, challenges in adapting in-person supervised exercise programs to remote delivery exist. This article discusses the key considerations for the effective and safe delivery of live-remote exercise, such as technological requirements, exercise professional skills, safety aspects, exercise programming features, social interactions, costs, and legal and ethical considerations. Considerations relevant for the design and execution of exercise oncology clinical trials and for community practice are described. Remaining knowledge gaps are outlined and point to opportunities to further inform evidence-based practice and practice-based evidence. |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Müller, Jana |b 1 |
700 | 1 | _ | |a Trevaskis, Mark |b 2 |
700 | 1 | _ | |a Kias, Alina |0 P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6 |b 3 |u dkfz |
700 | 1 | _ | |a Hiensch, Anouk E |b 4 |
700 | 1 | _ | |a Bland, Kelcey A |b 5 |
700 | 1 | _ | |a Lorenz, Maria C |b 6 |
700 | 1 | _ | |a Monninkhof, Evelyn M |b 7 |
700 | 1 | _ | |a Schmidt, Martina E |0 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac |b 8 |u dkfz |
700 | 1 | _ | |a Binyam, David |b 9 |
700 | 1 | _ | |a Clauss, Dorothea |0 P:(DE-He78)f52b77d7ab843c9b900134aafc61638a |b 10 |u dkfz |
700 | 1 | _ | |a Gunasekara, Nadira |b 11 |
700 | 1 | _ | |a Crisafio, Mary |b 12 |
700 | 1 | _ | |a De Jongh, Esther |b 13 |
700 | 1 | _ | |a Olivier, Franziska |b 14 |
700 | 1 | _ | |a Wengström, Yvonne |b 15 |
700 | 1 | _ | |a Steindorf, Karen |0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756 |b 16 |u dkfz |
700 | 1 | _ | |a Alves, Alberto J C |b 17 |
700 | 1 | _ | |a Campbell, Anna |b 18 |
700 | 1 | _ | |a Campbell, Kristin L |b 19 |
700 | 1 | _ | |a Stuiver, Martijn M |b 20 |
700 | 1 | _ | |a May, Anne M |b 21 |
700 | 1 | _ | |a Winters-Stone, Kerri |0 0000-0003-1706-8020 |b 22 |
773 | _ | _ | |a 10.1093/jncimonographs/lgaf029 |g Vol. 2025, no. 71, p. 351 - 359 |0 PERI:(DE-600)2044141-1 |n 71 |p 351 - 359 |t Journal of the National Cancer Institute / Monographs |v 2025 |y 2025 |x 1052-6773 |
909 | C | O | |o oai:inrepo02.dkfz.de:303953 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)f52b77d7ab843c9b900134aafc61638a |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-12 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-12 |
920 | 1 | _ | |0 I:(DE-He78)C110-20160331 |k C110 |l Bewegung, Krebsprävention und Survivorship |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C110-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|